Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood–brain barrier dysfunction
- 1 September 2014
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 277, 859-871
- https://doi.org/10.1016/j.neuroscience.2014.07.058
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerabilityNeuroscience, 2013
- Epilepsy: Ever-changing states of cortical excitabilityNeuroscience, 2012
- Cysteinyl-leukotriene receptor antagonist montelukast decreases blood–brain barrier permeability but does not prevent oedema formation in traumatic brain injuryBrain Injury, 2009
- A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1Brain, 2008
- The neuronal excitability time-dependently changes after lipopolysaccharide administration in mice: Possible role of cyclooxygenase-2 inductionEpilepsy Research, 2006
- Astrocyte–endothelial interactions at the blood–brain barrierNature Reviews Neuroscience, 2006
- Regulating leukotriene synthesis: The role of nuclear 5‐lipoxygenaseJournal of Cellular Biochemistry, 2005
- Biology and pathophysiology of leukotrienesCritical Reviews in Oncology/Hematology, 1996
- Pharmacological blood-brain barrier modification for selective drug deliveryJournal of Neuro-Oncology, 1995
- Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.Proceedings of the National Academy of Sciences of the United States of America, 1993